Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipation Builds for CoDiagnostics Quarterly Earnings Report

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Biotechnology Stock Exchange
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Co-Diagnostics (NASDAQ: CODX) is gearing up to unveil its latest quarterly earnings report on March 14, 2024. Analysts are predicting an EPS of $-0.20 for this quarter.

In the previous quarter, Co-Diagnostics surprised everyone by surpassing EPS expectations by $0.09, causing a 10.24% decrease in the share price the next day.

As of March 12, the company’s stock was valued at $1.175, marking a 60.14% decline over the past year. Investors are eagerly awaiting not only a strong earnings performance but also optimistic guidance for future growth, as this can have a significant impact on stock prices.

CODX Stock Price Analysis: Slight Drop in Momentum on March 13, 2024

On March 13, 2024, CODX stock experienced a slight drop in its price momentum, trading in the middle of its 52-week range and below its 200-day simple moving average. The stock opened at $1.23, which was $0.05 higher than its previous close. Despite opening higher, the price of CODX shares decreased by $0.00 since the market last closed, resulting in a 0.36% drop. This slight decrease may have been influenced by various factors such as market conditions, investor sentiment, or company-specific news. Investors and analysts may be closely monitoring CODX stock performance to gauge its future trajectory. It will be interesting to see how the stock performs in the coming days and whether it can regain momentum to move towards its 200-day simple moving average. As always, it is important for investors to conduct thorough research and analysis before making any investment decisions. Stock prices can be volatile and unpredictable, so it is crucial to stay informed and make informed decisions based on reliable information.

CODX Stock Performance Analysis: Revenue Fluctuations and EPS Trends on March 13, 2024

On March 13, 2024, CODX stock experienced some interesting fluctuations in its financial performance. According to data from CNN Money, the company reported a total revenue of $34.22 million over the past year, which represents a significant decrease of 65.04% compared to the previous year. However, when looking at the quarterly revenue, CODX saw a substantial increase of 1142.18% since the last quarter, with total revenue reaching $2.46 million.

In terms of net income, CODX reported a loss of $14.24 million over the past year, indicating a decrease of 138.84% compared to the previous year. However, the company managed to reduce its losses in the last quarter, with a net loss of $5.98 million, representing an increase of 32.93% since the previous quarter.

Earnings per share (EPS) also showed mixed results for CODX stock. The company reported an EPS of -$0.45 over the past year, reflecting a decrease of 136.9% compared to the previous year. However, there was a positive trend in the last quarter, with an EPS of -$0.20, indicating an increase of 33.56% since the previous quarter.

Overall, the financial performance of CODX stock on March 13, 2024, showed a mix of positive and negative trends. Investors will be closely monitoring CODX stock to see if these trends continue in the future.

Tags: CODX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Charts for stock trading

Stifel Analyst Reaffirms Buy Rating for Equinix with 960 Price Target

Bellevue dues

Analysts Remain Bullish on Alcon with Buy Ratings and Price Target Increases

why did walmart get rid of price scanners

Truist Securities Analyst Reaffirms Positive Outlook on Keros Therapeutics with 100 Price Target

Recommended

C3.ai Stock

C3.ai Shares Plunge Amid Mounting Challenges

2 weeks ago
Deutsche Bank Stock

Deutsche Bank Faces Critical Weekend with Dual Operational and Market Challenges

1 month ago
Airbnb Stock

Insider Selling and Institutional Uncertainty Cloud Airbnb’s Outlook

1 month ago
BioNTech Stock

Why BioNTech’s Strong Clinical Data Fails to Impress the Market

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Strong Earnings and Mixed Signals: Horace Mann Educators’ Q2 Performance

QuantumScape Shares Defy Insider Selling With Major Weekly Rally

Lockheed Martin’s Vectis: A New Era in Unmanned Aerial Combat

Dynex Capital’s Dividend Sustainability Questioned Amid Massive Payout Ratio

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

Nike Shares Face Critical Earnings Test

Trending

Maravai LifeSciences Holdings Registered (A) Stock
Analysis

Is There Any Hope Left for Maravai LifeSciences Investors?

by Dieter Jaworski
September 22, 2025
0

Maravai LifeSciences Holdings Registered (A) shares continue their relentless downward trajectory, leaving shareholders to question whether a...

G III Apparel Stock

G-III Apparel Shares Face Significant Headwinds Following Disappointing Earnings

September 22, 2025
Infinera Stock

Nokia Finalizes Landmark $2.3 Billion Acquisition of Infinera

September 22, 2025
Horace Mann Educators Stock

Strong Earnings and Mixed Signals: Horace Mann Educators’ Q2 Performance

September 22, 2025
QuantumScape Stock

QuantumScape Shares Defy Insider Selling With Major Weekly Rally

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Is There Any Hope Left for Maravai LifeSciences Investors?
  • G-III Apparel Shares Face Significant Headwinds Following Disappointing Earnings
  • Nokia Finalizes Landmark $2.3 Billion Acquisition of Infinera

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com